RESUMO
Forty-six subjects with hand dermatitis participated in a pilot study comparing a new semipermeable glove to a standard cotton glove. A variety of diagnoses were represented. Each subject received treatment with topical steroids and/or moisturizers and used one each of the experimental and cotton gloves for approximately one month. Physicians scored skin condition before and after treatment. Subjects evaluated skin comfort and practical aspects of using each type of glove. Thirty subjects completed the study protocol. The type of glove used had no impact on skin condition at follow up, with both groups of hands improving. Patients expressed a preference for the experimental gloves, noting improvements in skin and hand comfort, dexterity, cleanliness, and ease of use. Feedback suggested that the gloves will be well tolerated and patient compliance in using the gloves will be high. Evaluation of the gloves' value for prevention and chronic management of hand dermatitis is warranted.
Assuntos
Luvas Protetoras , Dermatoses da Mão/terapia , Administração Tópica , Terapia Combinada , Fármacos Dermatológicos/administração & dosagem , Estudos de Avaliação como Assunto , Gossypium , Humanos , Permeabilidade , Projetos Piloto , Esteroides/uso terapêuticoRESUMO
A 76-year-old woman with ovarian adenocarcinoma and sudden onset of many seborrheic keratoses is reported. This cutaneous sign, a marker of an internal malignancy, is known as the sign of Leser-Trélat. Its association with gynecologic neoplasms is reviewed.
Assuntos
Adenocarcinoma/patologia , Neoplasias Ovarianas/patologia , Adenocarcinoma/complicações , Idoso , Feminino , Humanos , Ceratose/complicações , Neoplasias Ovarianas/complicaçõesRESUMO
Serum lysozyme (Muramidase) levels in patients with localized and generalized granuloma annulare were measured by a turbidometric method. More lysozyme is present in the serum samples of patients with generalized granuloma annulare than patients with the localized form or normal controls. The mean level of patients with generalized disease was 9.27 mg/L compared with 5.96 mg/L for patients with localized disease and 6.8 mg/L for controls.